AI assistant
Scienture Holdings, Inc. — Director's Dealing 2020
Dec 16, 2020
35013_dirs_2020-12-16_f5c6a6b3-1270-43cd-bdcb-3232963e8c9f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TRXADE GROUP, INC. (MEDS)
CIK: 0001382574
Period of Report: 2020-12-14
Reporting Person: Patel Prashant (Director, President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-14 | Common stock | S | 7500 | $5.2937 | Disposed | 1260000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock | 400000 | Indirect |
| Common stock | 416667 | Indirect |
Footnotes
F1: The shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person, to satisfy the Reporting Person's tax liability in connection with the December 2020 vesting of certain restricted stock shares which were granted under the Company's 2019 Equity Incentive Plan, which award was exempt from Section 16(b) pursuant to Rule 16b-3.
F2: Represents the weighted sales price for all sales made on December 14, 2020, which were made in a range of between $5.22 and $5.34 per share. The Reporting Person will provide to the Commission, the Issuer or any stockholder, upon request, full information regarding the number of shares sold at each separate price.